Together, you and your healthcare provider can take control of migraine treatment—one day and one story at a time.
Acute
In a study of people who either took Nurtec ODT or placebo to treat their migraine attacks, 21.2% (142/669) of Nurtec ODT patients experienced pain freedom at 2 hours vs 10.9% (74/682) for placebo, and 35.1% (235/669) experienced freedom from their most bothersome symptom (selected from light sensitivity, sound sensitivity, or nausea) at 2 hours compared to 26.8% (183/682) for placebo. These benefits were sustained through 48 hours for some people.
Preventive
In a study of people who either took Nurtec ODT (348 people) or placebo (347 people) to prevent their migraine attacks, people taking Nurtec ODT experienced a greater reduction in mean monthly migraine days (MMDs) during weeks 9–12 (4.3 fewer MMDs for Nurtec ODT vs 3.5 fewer MMDs for placebo).
Ready to share your migraine story?
Tell us how long you’ve been on Nurtec ODT and how it may have helped your experience with migraine.